Skip to content
  • Home
  • Travel
  • Tourism
  • Lifestyle
  • Hotels
  • Event
  • Business
  • Transportation
  • Consumer
Menu

eTravel Wire

  • Home
  • Travel
  • Tourism
  • Lifestyle
  • Hotels
  • Event
  • Business
  • Transportation
  • Consumer

Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU
eTravel Wire/10313245

Trending...
  • Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation
  • Business Funding Assist Significantly Expands Funding Solutions, Empowering Businesses Across the U.S. and Canada
  • NBA Legend Jeremy Lin, Benny Luo and Sy Huq Team Up to Executive Produce Powerful New Short Film "Ayo, Check Up!"
Iohexol Injection Of Beilu Pharma Receives MA Beijing Beilu Pharmaceutical Co., Ltd.
MIYUN, China - eTravelWire -- Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regulations of the European Medicines Agency.

Certificate information:
  • Company name: Beijing Beilu pharmaceutical Co., Ltd.
  • Manufacturing address: No.3 Shuiyuan West Road, Miyun District, Beijing, China
  • Registration number: RVG 132878
  • Drug name: Iohexol injection 350mg(I)/ml
  • Issuing authority: Netherlands Medicines Evaluation Board (MEB)
The successful registration of Iohexol Injection in Netherland indicates that the product has undergone rigorous scientific evaluation by EMA, confirming its compliance with EU Good Manufacturing Practice (GMP), quality, safety and efficacy standards. This authorization enables commercial distribution in EU-approved countries. It creates conditions for speeding up the Mutual recognition procedures(MRP) among EU countries such as Germany, France, Italy and others as well. This will help Beilu Pharmaceutical further promote the expansion of its overseas market and enhance the international market competitiveness of its contrast agent products, which is expected to have a positive impact on the company's operations in the future.

More on eTravel Wire
  • Global Patient Organizations Applaud Historic Passage of Integrated Lung Health Resolution at World Health Assembly 78
  • Love, Laughter, And Legacy Collide In The Romantic Comedy "different With Me"
  • Natalie Jean Releases Heartfelt Tribute Single "What They Didn't See" Honoring Late Friend and Lyricist Michael Peloso
  • Wildlife Wednesdays: BK Adventure Launches $45 Dolphin & Manatee Tours Near Orlando
  • Business Funding Assist Significantly Expands Funding Solutions, Empowering Businesses Across the U.S. and Canada

Contact Information:
Beijing Beilu Pharmaceutical Co., Ltd.
https://www.beilupharma.com/
yanglm@beilupharma.com

Contact
Beijing Beilu Pharmaceutical Co., Ltd. 
***@beilupharma.com


Source: Beijing Beilu Pharmaceutical Co., Ltd. 

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on eTravel Wire
  • 150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs
  • Use Dogecoin (DOGE) to mine Bitcoin (BTC) and earn passive income at home
  • European Tech Startup RoarFun discovers a gap in the U.S. market with a branded racing simulator rental at Atlanta's MRO Americas Aviation Convention
  • Degrees of Justice: Attorney Frank Walker Charts the Future of Criminal Justice with Ph.D Degree
  • The Jesse Roldan Team and Biz Hub Financial Successfully Facilitate One-Day Closing for Investor Deal in Hellertown, PA
  • How Does Google Crawl Websites?
  • Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation
  • Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement
  • Acacia Africa Unveils 2025's Biggest Safari Travel Trends
  • CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
  • $10 Million Plan to Acquire Successful Remote Lottery Platform: Expanding Global Footprint into Live Entertainment: Lottery.com (Stock Symbol: LTRY)
  • Assent Launches Carbon Border Adjustment Mechanism Solution to Help Manufacturers Meet Regulatory Requirements
  • Q1 2025 Revenue Soars 92% to $1.13M on Strategic Acquisitions, Organic Growth & Breakthroughs in AI Drones & Quantum Tech: ZenaTech Stock Symbol: ZENA
  • Travel jobseekers rise despite Easter holidays
  • US Van Rental Expands Premium Van Rental Services in Los Angeles with Flexible Airport Drop off
  • Savista Retreat Announces Monthly Yoga, Wellness & Experiential Retreats in Jaipur
  • Robert Tsigler Selected by NADC as Top 1% Attorney in the U.S. for 2025
  • **Award-Winning Dystopian Book Series Hitting Too Close to Home**
  • Neoware Unveils Strategic Transformation as a Specialist "Data to Intelligence" Partner
  • Moab Adventure Center Unveils 2025 Guide to the Best Hikes in and Around Arches National Park
Next Article _docTitle2

Related Posts

_docTitle2

_docDesc2
Read More about _docTitle2

Popular on eTravelWire

  • New Podcast "Change Cycle" Unpacks the Complexity of Driving Systemic Change Toward a Circular Economy - 199
  • SSATI Completes Acquisition of Invex Technology Solutions and ITIC Corporation's Government Support Services - 179
  • L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG) - 166
  • $4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression, PTSD: NRx: Stock Symbol: NRXP - 147
  • Barcelona-based Neurosurgical Specialist Awarded Designation of International Center of Excellence for Ehlers Danlos Syndrome - 139
  • Mission 3A Establishes Healthcare Advisory Board with Addition of Industry Leaders Patrick Fisher, Kevin Cordell, and Dr. Greg Berlet - 128
  • NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3 - 120
  • Pregis Expands Multi-Layer Technology for High-Performance Barrier Films at Anderson Facility - 118
  • Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads - 117
  • Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression - 114

Similar on eTravelWire

  • Mental Health Watchdog Calling for a Ban on the Use of the Electroshock Machine in Florida
  • Global Patient Organizations Applaud Historic Passage of a Resolution at WHA 78: "Skin diseases as a global public health priority"
  • Global Patient Organizations Applaud Historic Passage of Integrated Lung Health Resolution at World Health Assembly 78
  • Leadership Expert and Author Adam Holbrook Launches Breakthrough Book: Character Evolution
  • Solomon Eye Appoints Dr. Nancy Draskovic as Clinical Director of Ocular Surface Disease
  • Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation
  • Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement
  • CEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
  • Savista Retreat Announces Monthly Yoga, Wellness & Experiential Retreats in Jaipur
  • Neoware Unveils Strategic Transformation as a Specialist "Data to Intelligence" Partner
Theme by Bloompixel. Proudly Powered by WordPress
  • Contribute
  • Terms of Service
  • Privacy Policy
  • Contact Us